[go: up one dir, main page]

ES2093980T3 - Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano. - Google Patents

Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano.

Info

Publication number
ES2093980T3
ES2093980T3 ES93918065T ES93918065T ES2093980T3 ES 2093980 T3 ES2093980 T3 ES 2093980T3 ES 93918065 T ES93918065 T ES 93918065T ES 93918065 T ES93918065 T ES 93918065T ES 2093980 T3 ES2093980 T3 ES 2093980T3
Authority
ES
Spain
Prior art keywords
enzymatic
teno
produce
reduction process
asymmetric reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93918065T
Other languages
English (en)
Inventor
Robert Antony Holt
Stuart Richard Rigby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26301521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2093980(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB929218502A external-priority patent/GB9218502D0/en
Priority claimed from GB939303824A external-priority patent/GB9303824D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ES2093980T3 publication Critical patent/ES2093980T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/185—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/002—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UN COMPUESTO DE FORMULA (I) EN EL QUE X ES HIDROGENO O UN GRUPO DE FORMULA - SO2NH2, SE REDUCE A LA FORMA (4S, 6S) TRANS DEL ALCOHOL CORRESPONDIENTE, MEDIANTE UN SISTEMA DE REDUCCION ENZIMATICA.
ES93918065T 1992-08-28 1993-08-20 Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano. Expired - Lifetime ES2093980T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929218502A GB9218502D0 (en) 1992-08-28 1992-08-28 Asymmetric reduction process
GB939303824A GB9303824D0 (en) 1993-02-25 1993-02-25 Asymmetric reduction process

Publications (1)

Publication Number Publication Date
ES2093980T3 true ES2093980T3 (es) 1997-01-01

Family

ID=26301521

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93918065T Expired - Lifetime ES2093980T3 (es) 1992-08-28 1993-08-20 Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano.

Country Status (12)

Country Link
US (1) US5580764A (es)
EP (1) EP0658211B2 (es)
JP (1) JP3333206B2 (es)
KR (1) KR100319837B1 (es)
AT (1) ATE144795T1 (es)
AU (1) AU4729193A (es)
CA (1) CA2142444C (es)
DE (1) DE69305748T3 (es)
DK (1) DK0658211T4 (es)
ES (1) ES2093980T3 (es)
FI (1) FI106565B (es)
WO (1) WO1994005802A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3279671B2 (ja) * 1992-09-28 2002-04-30 鐘淵化学工業株式会社 チエノチオピラン誘導体の製造方法
US5474919A (en) * 1994-09-13 1995-12-12 Merck & Co., Inc. Bioconversion process for the synthesis of transhydroxy sulfone by Rhodotorula rubra or Rhodotorula piliminae
IL132500A0 (en) 1998-10-29 2001-03-19 Pfizer Prod Inc Stereoselective microbial reduction of a racemic tetralone
US6451587B1 (en) 1999-09-29 2002-09-17 Pfizer Inc. Microbial asymmetric reduction of 2-chloro-1-[-6-(2,5-dimethyl-pyrrol-1-yl)-pyridin-3-yl]-ethanone
ES2177415B1 (es) 2000-09-04 2004-10-16 Ragactives, S.L. Procedimiento para la obtencion de 4-alquilamino-5, 6-dihidro-4h-tieno-(2,3b)-tiopiran-2-sulfonamida-7-dioxidos, e intermedios.
US9097692B2 (en) * 2010-10-01 2015-08-04 Aug. Hedinger Gmbh & Co. Kg Method for quantitatively determining impurities in glycerin
SI2683724T1 (sl) 2011-03-10 2015-08-31 Zach System S.P.A. Asimetrični redukcijski proces
ITMI20110365A1 (it) * 2011-03-10 2012-09-11 Zach System Spa Processo di riduzione asimmetrica
ITMI20111028A1 (it) * 2011-06-08 2012-12-09 Zach System Spa Processo di riduzione asimmetrica
KR102019953B1 (ko) 2017-03-02 2019-11-04 (주)삼성컨트롤밸브 자동밸브를 이용한 분무 장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
US4968815A (en) * 1990-04-16 1990-11-06 Merck & Co., Inc. Synthesis of (S)-3-(thien-2-ylthio)butyric acid analogs
US5039802A (en) * 1990-04-18 1991-08-13 Merck & Co., Inc. Arylation process for preparation of chiral catalysts for ketone reduction
US5474919A (en) * 1994-09-13 1995-12-12 Merck & Co., Inc. Bioconversion process for the synthesis of transhydroxy sulfone by Rhodotorula rubra or Rhodotorula piliminae

Also Published As

Publication number Publication date
EP0658211A1 (en) 1995-06-21
DE69305748D1 (de) 1996-12-05
DE69305748T2 (de) 1997-03-13
CA2142444C (en) 2008-08-05
FI950892L (fi) 1995-02-27
FI950892A0 (fi) 1995-02-27
KR100319837B1 (ko) 2002-04-22
US5580764A (en) 1996-12-03
JPH08501216A (ja) 1996-02-13
WO1994005802A1 (en) 1994-03-17
ATE144795T1 (de) 1996-11-15
KR950703062A (ko) 1995-08-23
CA2142444A1 (en) 1994-03-17
JP3333206B2 (ja) 2002-10-15
EP0658211B2 (en) 2003-12-10
DK0658211T3 (da) 1997-04-28
FI106565B (fi) 2001-02-28
DK0658211T4 (da) 2004-04-13
DE69305748T3 (de) 2004-07-29
AU4729193A (en) 1994-03-29
EP0658211B1 (en) 1996-10-30

Similar Documents

Publication Publication Date Title
ES2071351T3 (es) Un procedimiento para la produccion de 6,12-dihidro-6-hidroxicannabidiol y el uso del mismo para la produccion de trans-delta-9-tetrahidrocannabinol.
ES2107056T3 (es) Inhibicion por antraquinonas de la produccion de metano en bacterias metanogenicas.
ES2073529T3 (es) Inhibidor de fosfolipasa a2, microorganismos que producen este inhibidor y procedimiento para su produccion.
ES2098921T3 (es) Composiciones de cetoconazol de uso topico.
ES2104386T3 (es) Compuesto intermedio para la acitromicina.
ES2093980T3 (es) Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano.
MX173310B (es) Derivados fenolicos de benzotiazol como inhibidores de la corrosion
AR006058A1 (es) Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido
ES2164700T3 (es) Procedimiento para preparar carbinoles de aril-piperidina.
FI940731A0 (fi) Amiditetratsolit ACAT-inhibiitoreina
NO308743B1 (no) FremgangsmÕte for fremstilling av N-acetyl- neuraminsyrederivater
MX167529B (es) Antiozonantes que no manchan y que manchan ligeramente
MX9401260A (es) COMPUESTO DE BIBENZOATO DE BIS-ß-HIDROXIETILO.
ES2093975T3 (es) Agentes antiespumantes cerrados por grupos terminales.
ES8707738A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihidroorotil-histidil-prolinamida
FI861947A0 (fi) Hexensyror.
ES2183860T3 (es) Procedimiento para producir n-terc butil-2-pirazincarboxamida y n-ter-butil-2-piperazincarboxamida.
ES2053407T3 (es) Procedimiento para inhibir el crecimiento de microorganismos en liquidos acuosos.
ES2097435T3 (es) Derivados de 2,16-bispiperidinilandrostano monocuaternarios.
YU46935B (sh) Pseudo-primicinski kompleks formule (i) i njegove adicione soli sa kiselinama kao i postupak za pravljenje istih
SE8803143L (sv) Alternativa energisubstrat
ES2046941B1 (es) Procedimiento de obtencion de trioxo-pirazolo, (2,1) benzotiazepinas>
EP0596112A4 (en) Macrolide compound and its preparation.
ES2115950T3 (es) Preparacion de n-cianoditioiminocarbonatos disustituidos, simetricos o asimetricos.
GEP19971039B (en) Method for production of acrylic acid

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 658211

Country of ref document: ES